<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03745118</url>
  </required_header>
  <id_info>
    <org_study_id>18-008357</org_study_id>
    <nct_id>NCT03745118</nct_id>
  </id_info>
  <brief_title>Development of a Practical, Minimally Invasive Seizure Gauge</brief_title>
  <official_title>Development of a Practical, Minimally Invasive Seizure Gauge</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Mayo Clinic</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Mayo Clinic</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      The researchers are trying to assess changes in physiological signals before and during
      seizures.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Subjects that are undergoing video EEG monitoring in the hospital for their epilepsy at Mayo
      Clinic will be consented to participate in this study for a minimum of two days and/or the
      duration of their hospital stay for their clinical care. Subjects will be asked to wear up to
      4 different commercially available seizure detection devices and complete surveys.

      In the second year of the study patients who have implanted devices capable of recording or
      detecting seizures will be recruited to wear a noninvasive biosensor for multiple months.
      This data will be used to develop algorithms capable of detecting and/or forecasting
      seizures.

      When the subjects clinical EEG monitoring is completed data scientists will analyze the data
      to identify patterns.
    </textblock>
  </detailed_description>
  <overall_status>Enrolling by invitation</overall_status>
  <start_date type="Actual">November 19, 2018</start_date>
  <completion_date type="Anticipated">December 2020</completion_date>
  <primary_completion_date type="Anticipated">December 1, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Assessment of Physiological Signals Measurable with Wearable Sensors</measure>
    <time_frame>2-10 days approximately</time_frame>
    <description>We will collect physiological signals with the five wearable, noninvasive biosensors listed below in Mayo patients undergoing scalp-recorded video EEG and invasive stereotactic EEG/video monitoring as part of their clinical epilepsy evaluation. We will evaluate biosignals based on data quality and reliability, and subject comfort and ease of use.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Pattern Analysis</measure>
    <time_frame>2-10 days approximately</time_frame>
    <description>We will apply data mining and machine learning methods to search for patterns in the collected physiological signals and correlate these patterns with the timing of seizures identified by the patient's clinical video-EEG monitoring.</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">80</enrollment>
  <condition>Epilepsy</condition>
  <arm_group>
    <arm_group_label>Monitoring Device</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Subjects will be asked to wear up to 4 different noninvasive seizure detection devices including EpiTel EpiLog, Byte Flies Sensor Dots, Empatica E4, Biovotion Everion, GeneActiv</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>EpiTel EpiLog</intervention_name>
    <description>Plastic pad that is about the size of a house key, and will be adhered to your scalp with gel</description>
    <arm_group_label>Monitoring Device</arm_group_label>
    <other_name>Epilog</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Byte Flies Sensor Dots</intervention_name>
    <description>Plastic pads that will be adhered to your chest area</description>
    <arm_group_label>Monitoring Device</arm_group_label>
    <other_name>Byteflies</other_name>
    <other_name>Sensor Dots</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Empatica E4</intervention_name>
    <description>wearable seizure detection wristband</description>
    <arm_group_label>Monitoring Device</arm_group_label>
    <other_name>E4 Wristband</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Biovotion Everion</intervention_name>
    <description>wearable seizure detection device armband that is attached to upper arm</description>
    <arm_group_label>Monitoring Device</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>GeneActiv</intervention_name>
    <description>wearable seizure detection watch</description>
    <arm_group_label>Monitoring Device</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients with epilepsy- scalp EEG or invasive EEG monitoring for clinical care, or an
             implanted device capable of monitoring brain activity and identifying seizures (e.g.
             NeuroPace RNS, Medtronic PC+S, Medtronic RC+S)

          -  Pediatric subjects 7 years of age or older.

        Exclusion Criteria:

          -  Cognitive or psychiatric condition rendering patient unable to cooperate with data
             collection, or manage and recharge smart watch and tablet computer devices.

          -  Presence of open or healing wounds near monitoring sites (infection risk).
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>7 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Benjamin (Ben) H. Brinkmann, Ph.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Mayo Clinic</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Mayo Clinic</name>
      <address>
        <city>Rochester</city>
        <state>Minnesota</state>
        <zip>55905</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <link>
    <url>https://www.mayo.edu/research/clinical-trials</url>
    <description>Mayo Clinic Clinical Trials</description>
  </link>
  <link>
    <url>https://www.epilepsy.com/article/2019/10/driving-therapeutic-innovations-my-seizure-gauge-challenge</url>
    <description>Epilepsy Foundation My Seizure Gauge Challenge</description>
  </link>
  <verification_date>January 2020</verification_date>
  <study_first_submitted>November 14, 2018</study_first_submitted>
  <study_first_submitted_qc>November 14, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">November 19, 2018</study_first_posted>
  <last_update_submitted>January 16, 2020</last_update_submitted>
  <last_update_submitted_qc>January 16, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">January 21, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Mayo Clinic</investigator_affiliation>
    <investigator_full_name>Benjamin H. Brinkmann</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>Seizure</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Seizures</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

